Search

Search

Home
...
Research Domains Biomedical and Clinical Sciences Oncology and Carcinogenesis Predictive and prognostic markers
Research Domains
Biomedical and Clinical Sciences
Oncology and Carcinogenesis
Predictive and prognostic markers
ASO Visual Abstract: Hepatic and Overall Progression-Free Survival After Percutaneous Hepatic Perfusion as First- or Second-Line Therapy for Metastatic Uveal Melanoma

ASO Visual Abstract: Hepatic and Overall Progression-Free Survival After Percutaneous Hepatic Perfusion as First- or Second-Line Therapy for Metastatic Uveal Melanoma

Helana Ghali ¹, Michelle M Dugan ², Shaliz Aflatooni ¹, Aleena Boby ¹, Danielle K DePalo ^2,3, José Laborde ⁴, Junsung Choi ^5,6, Altan F Ahmed ^5,6, Jonathan S Zager ^7,8

Helana Ghali ¹, Michelle M Dugan ², Shaliz Aflatooni ¹

¹University of South Florida Morsani College of Medicine, Tampa, FL, USA.
²Department of Cutaneous Oncology, Moffitt Cancer Center, Tampa, FL, USA.
³Department of General Surgery, University of Massachusetts Chan Medical School, Boston, MA, USA.
⁴Department of Biostatistics and Bioinformatics, Moffitt Cancer Center, Tampa, FL, USA.
⁵Department of Diagnostic Imaging and Interventional Radiology, Moffitt Cancer Center, Tampa, FL, USA.
⁶Department of Oncologic Sciences, University of South Florida Morsani College of Medicine, Tampa, FL, USA.
⁷Department of Cutaneous Oncology, Moffitt Cancer Center, Tampa, FL, USA. jonathan.zager@moffitt.org.
⁸Department of Oncologic Sciences, University of South Florida Morsani College of Medicine, Tampa, FL, USA. jonathan.zager@moffitt.org.

⁰University of South Florida Morsani College of Medicine, Tampa, FL, USA.

Annals of Surgical Oncology +

|

October 8, 2024

|

October 8, 2024

Related Experiment Videos

Contact us if these videos are not relevant.

Isolated Hepatic Perfusion as a Treatment for Liver Metastases of Uveal Melanoma

Isolated Hepatic Perfusion as a Treatment for Liver Metastases of Uveal Melanoma

Published on: January 25, 2015

Percutaneous Hepatic Perfusion (PHP) with Melphalan as a Treatment for Unresectable Metastases Confined to the Liver

Percutaneous Hepatic Perfusion (PHP) with Melphalan as a Treatment for Unresectable Metastases Confined to the Liver

Published on: July 31, 2016

Minimally Invasive Isolated Limb Perfusion (MI-ILP) for Locally Advanced Melanomas and Sarcomas of the Extremity

Minimally Invasive Isolated Limb Perfusion (MI-ILP) for Locally Advanced Melanomas and Sarcomas of the Extremity

Published on: January 31, 2025

See all related videos

Summary

No abstract available on PubMed

Related Experiment Videos

Contact us if these videos are not relevant.

Isolated Hepatic Perfusion as a Treatment for Liver Metastases of Uveal Melanoma

Isolated Hepatic Perfusion as a Treatment for Liver Metastases of Uveal Melanoma

Published on: January 25, 2015

Percutaneous Hepatic Perfusion (PHP) with Melphalan as a Treatment for Unresectable Metastases Confined to the Liver

Percutaneous Hepatic Perfusion (PHP) with Melphalan as a Treatment for Unresectable Metastases Confined to the Liver

Published on: July 31, 2016

Minimally Invasive Isolated Limb Perfusion (MI-ILP) for Locally Advanced Melanomas and Sarcomas of the Extremity

Minimally Invasive Isolated Limb Perfusion (MI-ILP) for Locally Advanced Melanomas and Sarcomas of the Extremity

Published on: January 31, 2025

See all related videos

Share

X
Facebook
LinkedIn
YouTube

ABOUT JoVE

Overview
Leadership
Blog
JoVE Help Center

AUTHORS

Publishing Process
Editorial Board
Scope & Policies
Peer Review
FAQ
Submit

LIBRARIANS

Testimonials
Subscriptions
Access
Resources
Library Advisory Board
FAQ

RESEARCH

JoVE Journal
Methods Collections
JoVE Encyclopedia of Experiments
Archive

EDUCATION

JoVE Core
JoVE Business
JoVE Science Education
JoVE Lab Manual
Faculty Resource Center
Faculty Site

Terms & Conditions of Use
Privacy Policy
Policies